Equivalent Gain-of-Function Variants in <i>KCNK3</i> and <i>KCNK9</i> and their Contribution to Distinct TASK K2P Channelopathies
Kate M. Crowther(University of Oxford), Stephen J. Tucker(University of Oxford), Carlos A. Bacino(Baylor College of Medicine), Alistair Mathie(University of Westminster), Simon Newstead(University of Oxford), Saskia B. Wortmann(Paracelsus Medical University), Nina Barišić(University Hospital Centre Zagreb), Jill A. Rosenfeld(Baylor College of Medicine), Caroline F. Wright(University of Exeter), James Fasham(University of Exeter), Karin E. J. Rödström(University of Oxford), Emma L. Veale(Medway School of Pharmacy), Linford Williams(Children's Hospital of Pittsburgh), Natalie Hauser(Inova Fairfax Hospital), Janina Sörmann(University of Copenhagen), Thibault Jouen-Tachoire(University of Oxford), Henry Houlden(Queen Mary University of London), Reza Maroofian(University College London), Peter Proks(University of Oxford), Peter-Rory Hall(University of Oxford), RaeLynn Forsyth(Children's Hospital of Pittsburgh), Vincenzo Salpietro Damiano(University of L'Aquila), Thomas D. Mueller(University of Würzburg)
Cited by 1
Related Papers
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
Guide to Receptors and Channels (GRAC), 5th edition
|British Journal of Pharmacology|2011|1.9k
Resolution of Disease Phenotypes Resulting from Multilocus Genomic Variation
|New England Journal of Medicine|2016|774
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors
|British Journal of Pharmacology|2019|712
Guide to Receptors and Channels (GRAC), 3rd edition
|British Journal of Pharmacology|2008|508